Laden…
1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol
Trihexyphenidyl is a centrally acting anticholinergic agent primarily used for the treatment of Parkinson's symptoms. It blocks muscarinic acetylcholine receptors and thereby exerts spasmolytic and antiparkinsonian effects. Side effects may include anticholinergic effects such as dry mouth, cognitive impairments, and tachycardia. Due to its pharmacological profile, improper use may lead to cognitive disturbances and delirium.
Translation in progress
The German version has more complete content. This English page is being expanded; safety-critical risk and interaction sections may still appear while translation continues.
Receptor Targets
Mechanism of Action
Designations
IUPAC: 1-cyclohexyl-1-phenyl-3-piperidino-propan-1-ol
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Synapedia Evidence
Effects & Pharmacology translation in progress
English prose is being expanded. The German version currently has more detail.
Total duration 6-12 hours
Peak
2-4 hours
Onset
1-2 hours
Total duration
6-12 hours
After effects
Unclear
Start low. Individual sensitivity varies.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, combinations, and pre-existing conditions significantly affect outcomes. These figures are not dosing recommendations — they describe reported ranges, not safe amounts.
Risks
Summary
Mögliche Nebenwirkungen umfassen Mundtrockenheit, Schwindel und Verwirrtheit.
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Interaction details from the knowledge layer are still being translated.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.